共 442 条
[81]
Lipka S(2006)Cytokine expression in normal and inflamed oesophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis J Pediatr Gastroenterol Nutr 330 102-680
[82]
Kumar A(2015)Oesophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition Exp Cell Res 108 954-165.e163
[83]
Richter JE(2001)Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response J Allergy Clin Immunol 116 536-1381
[84]
Aceves SS(2006)Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis J Clin Invest 122 425-undefined
[85]
Lucendo AJ(2008)Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis J Allergy Clin Immunol 388 2115-undefined
[86]
Molina Infante J(2016)Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial Lancet 388 2128-undefined
[87]
Dellon ES(2016)Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial Lancet 330 864-undefined
[88]
Kim HP(2009)The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases J Pharmacol Exp Ther 389 2287-undefined
[89]
Sperry SL(2016)Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial Lancet 3 673-undefined
[90]
Rybnicek DA(2002)Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP Nat Immunol 126 160.e163-undefined